Event Content

Cytiva helps the biopharma industry reduce Scope 3 emissions with strategies such as embedding ecodesign principles across our product portfolio and advancing process intensification approaches. Through the use of primary emissions data, we empower manufacturers to make smarter, data-driven sustainability ...

Green chemistry and low-carbon technologies, including continuous flow chemistry and biocatalysis, contribute significantly to sustainable pharmaceutical manufacturing. PharmaBlock's innovative approaches in this field, recognized by the 2023 and 2024 ACS CMO Excellence in Green Chemistry Awards, demonstra...

The biotech industry faces rapid transformation driven by technological innovation, global market shifts, and healthcare cost pressures, creating critical demand for cost-efficient, scalable biologics manufacturing. Enzene's response is EnzeneX™ 2.0, the next evolution of their Fully-Connected Continuous M...

ReciBioPharm introduces an advanced process analytical technology (PAT) platform for RNA therapeutics that leverages in-line PAT and machine learning to enable real-time monitoring, control, and optimization. PAT tools provide continuous data throughout the production process—from plasmid linearization to ...

In this talk we explore the role of AI and ML in modernizing manufacturing, particularly in pharma and biotech. Despite the immense potential, the industry is still transitioning from traditional processes to digitalization, overcoming hurdles like regulatory compliance, cultural shifts, fulfilment of gap...

Key discussion points: 1. Introduction of botanical prescription drugs, 2. Outline of a growing interest in evidence based natural products including stats from practitioners and patients, 3. Botanical prescription drug - clinical trial requirements, 4. Advancements in clinical trials in the research of co...

• Alternative Approaches to Boost Patient Enrolment Amid Recruitment Challenges • How the Rising Pressures of Patient Recruitment Are Challenging Traditional Enrolment Methods

Amid growing global demands and complexities, resilience and agility have become essential for success in today’s pharmaceutical supply chains. The COVID-19 pandemic, geopolitical tensions, and reliance on foreign manufacturing have underscored vulnerabilities in the supply of APIs—the building blocks of m...

The presentation addresses the challenges of transitioning from traditional to sustainable blister packaging. While taking a closer look at thermoforming processes, barrier properties, drug stability and push-through force in pharmaceutical packaging, we will explore how scientific services can support the...

This session will begin with an introduction to Informa's Sustainability Partner, Adelphe, offering an overview of the organization and its mission. • Experts will discuss what defines recyclable packaging, the current recycling pathways, and what can be expected in the future. • Additionally, the s...

We have ready capacity, when you need it. • For our Pharma-, Diagnostics- and MedTec customers we build ahead according to their future needs and scale-up scenarios. • See our recent growth case studies and learn how we can secure your program success and speed up your time-to-market. MGS is your com...

The current exemptions from PPWR and the like which are afforded to pharma packaging won't last forever. In this session we shall explore sustainable solutions that are being delivered industry wide, as well as considering specific material changes which can reduce overall carbon emissions.

In this presentation, we introduce our most recent development – a versatile, reusable, and connected electromechanical solution that upholds the concept of drug agnosticism, platform flexibility, ease-of-use, as well as device programmability. By leveraging technological application expertise, we demonstr...

With the packaging market poised for significant growth in the next decades, CPHI Milan's opening keynote will explore the key drivers fuelling this expansion. From the rapid evolution of drug delivery systems to the surge in generic drug consumption and the industry's continuous innovation, discover the f...

Today’s practice of single-use plastic packaging in pharma industry is a waste and emission driver consuming finite resources. As of today, virgin material is applied to ensure patient safety resulting in large quantities of waste. Three pharma pioneers addressed this issue led by the question: How to over...

Aptar Pharma's presentation entitled "Innovations in Inhalation" explores the current extensive portfolio of high-quality OINDP (Orally Inhaled and Nasal Drug Products) delivery devices. The presentation also highlights Aptar Pharma's comprehensive services which support respiratory drug development, inclu...

• Beyond traditional roles: Explore how excipients are no longer passive additives but active contributors to drug efficacy and delivery, offering diverse functionalities • Precision medicine and tailored therapies: Delve into the role of excipient solutions in enabling precision medicine by allowing...

This session will provide a comprehensive overview of the challenges and opportunities in decarbonizing pharmaceutical supply chains, showcasing the potential of industry-wide programs like Energize and the practical guidance offered by the PSCI Decarbonization Maturity Model. • Assessing the challenge...

Ingenza is changing the game in drug substance production by embracing the concept of employing the best of what both chemistry and biology have to offer. We integrate fermentative, biocatalytic and chemical synthetic transformations at any stage in the manufacturing process. We are versatile and adaptable...

What are blister packs, and why are they so important? How have they changed over the years, and where are they heading? This presentation will consider a history of how blister packs have benefitted the supply of medicines to patients worldwide, and how they are continuing to evolve within an increasi...

Today’s medicine and therapeutics encompass fairly complex formulations. The device design needs to not only incorporate the challenging needs of the formulation but also address patient optimized administration and deliver consistent results. The success of the clinical outcome is dependent on the deliver...

This session will explore: • The role of the device supplier in overall product sustainability • Benefits of lifecycle assessment (LCA) in device development • Trade-offs between usability, cost of goods, and carbon footprint • Challenging Pharma to close the circle and enable better solutions

Meet industry sustainability experts in an informal setup for an open discussion on what matters the most for you as part of the Pharma industry. What are your current sustainability planning issues and how could you solve them? What could be your next steps and with whom do you need to collaborate to reac...

Join us as we dive into the key considerations of choosing a CDMO as a biotech, and how to select the perfect partner: • Establishing a pre-partner checklist of what you need (regulation, manufacturing technology, and logistics) to avoid unnecessary costly measures • Why understanding your molecul...

TBC

Reactions involving metal catalysis, both homogeneous as well as heterogenous catalysis and chiral organic synthesis are always subjects of great interest in organic synthesis. All these reactions involve the usage of metals such as, Ni, Pd, Pt, Rh, Ru etc.. Not only the cost of these metals but also the e...

BSI – set the scene of the challenge of manufacturing antibiotics and the environment - 3 mins
Centrient – what we have done so far to invest in mitigating environmental threat?– 5 mins BSI – One Health approach towards setting industry standard and certification for combatting antibiotics dischar...

In The CDMO X-Factor,Andrew Carpenter, Ph.D, a leader in cGMP manufacturing of small molecule APIs, with a passion for continuous manufacturing, will challenge the boundaries of what the industry once believed possible for advanced pharmaceutical ingredients manufacturing. This engaging session will includ...

As we bring in 2023, pharmaceutical companies will undoubtedly be looking ahead. But how will the events of the past two COVID years influence future aspirations? In the past, pharmaceutical companies used a mix of bottom-up and top-down processes to budget for the next fiscal year, and then made quarterly...

In pharma, it is essential to identify the right partner to ensure a successful outcome. Time and time again, mistakes have been made in this process, causing clinical studies to fail and for the company to take a heavy hit. Want to avoid this? join our one-hour masterclass where we will devise a checklist...

M&A plays a pivotal role in pharma growth as it enables companies to streamline their operations and strategies while reducing overhead costs, which can contribute to profit growth. To understand more, join our informative session, where our market experts will highlight and discuss the latest trends in th...

Lyophilization (freeze drying) is a proven process for increasing the shelf life of vaccines, biologics and other injectables. But delivering these products requires several use steps that make them challenging to administer, particularly by patients and caregivers in non-clinical settings. To address thes...

We at Körber believe the pharmaceutical industry will ultimately dispense of plastic packaging within a few years. Our Rondo Solutions are pioneering when it comes to sustainability. Today pharmaceutical packaging expects to be innovative, compact, safe, and environmentally friendly. That’s because opin...

Transitioning drugs from IV to subcutaneous (SC) delivery brings new requirements and impacts program considerations for combination product development. In this session, we identify trade-offs that pharma weighs to de-risk combination product development programs involving large volume subcutaneous (LVSC...

In recent years there are several market trends which are influencing the design of drug delivery devices. The shift to patient care outside the traditional healthcare setting, accelerated by the pandemic, has led to an increase in patient self- treatment. This has also resulted in the need for connected d...

Innovative Ready-to-Use Vial Platform for the Pharmaceutical Industry. Gerresheimer AG and Stevanato Group are addressing rising demand for RTU vials in the market and the partnership serves as a market enabler to fully support customers’ evolving needs and establish a gold standard in the industrial filli...

Worldwide, people are increasingly health-conscious and aware of the impact of individual lifestyle choices on their health and the health of others. In the latest years, consumers seek more and more transparency from companies through their brand, product manufacturing, and actions that promote well-being...

For the past few years, the traditional one-size-fits-all go-to-market strategy, predominantly based on customer interactions through physical channels, has failed to support drug launches and meet business objectives. Inadequate or incomplete understanding of customer needs has been identified as one of t...

OXYCAPT is a multilayer plastic vial that consists of three layers, COP/New Polyester/COP. The product has achieved excellent oxygen & ultraviolet (UV) light barrier, very low extractables, high pH stability, low protein adsorption, high transparency, high break resistance, lightweight, etc. For example, t...

The presentation will be about the Gerresheimer – roadmap to decarbonization. The speaker will cover supplier-specific approaches like the furnace technology. Furthermore, Value-chain-comprising approaches in Ph-business (eg eco-design development) will be explained. In the end, success stories about joint...

In this webinar, originally broadcast as a part of Pharmapack Europe 2022, speakers from STERIS will be describing the methodology for transferring the sterilization process of medical or pharma products from one radiation technology to another (e.g. gamma to X-ray).

In this webinar, originally broadcast as a part of Pharmapack Europe, Eve-Marie Vaccaro, Global Sales & Operation Planner, and Edgar Bauer, Global Key Account Manager Bausch+Ströbel from BD Medical - Pharmaceutical Systems discuss how VHP sterilization is a viable alternative for ensuring improved patient ...

Originally broadcast as part of the CPHI Monthly Podcasts Series Smart devices and their companion apps are transforming the patient experience and moving healthcare management from hospitals to homes. However, this digital shift can prove challenging for some users. In the latest instalment of our p...

The webinar addresses the need for new modalities, evolution of bio manufacturing of new modalities, and comparison with semiconductor manufacturing. This session was broadcast as part of the CPHI North America show.

Join our panel discussion, where out experts will conduct a deep dive through the challenges in drug manufacturing. Key discussion points include: Bottlenecks in skilled workforce and what can be done to overcome this Assessing the challenges in both product and manufacturing quality and identifying...

In this webinar, originally broadcast as part of CPHI NA, Michael Sassano, CEO and Chairman, Somai Pharmaceuticals discusses: • Global Pharmaceutical Cannabis market and the history of recent growth • Current trends in the Medical Cannabis market versus the Canadian and American experience • Herbal M...

In this webinar, originally broadcast as a part of Pharmapack Europe 2022, speaker Nigel Langley, Director Technical Service & Scientific Affairs, BASF Pharma Solutions reviews the 'Novel Excipient Review Pilot Program'. Launched at the end of 2021, the voluntary Novel Excipient Review Pilot Program (Pilot...